期刊文献+

原发性醛固酮增多症患者血钾水平的影响因素分析 被引量:7

Analysis of related factors of blood potassium in patients with primary aldosteronism
下载PDF
导出
摘要 目的分析原发性醛固酮增多症患者血钾水平的影响因素。方法回顾性分析原发性醛固酮增多症患者82例临床资料,将其分为正常血钾组和低血钾组。探讨原发性醛固酮增多症患者血钾与其血醛固酮、肾素、血管紧张素Ⅱ及醛固酮肾素活性比值(ARR)的关系。结果原发醛固酮增多症患者血钾与醛固酮肾素活性比值(ARR)有相关性(P<0.05),正常血钾组与低血钾组ARR值差异有统计学意义(P<0.05)。结论在原发性醛固酮增多症患者中,醛固酮肾素活性比值反映其血钾水平。 Objective To analyse the related factors of blood potassium in patients with primary aldosteronism. Meth-ods Clinical date of 82 patients with primary aldosteronism were retrospectively analyzed. They were divided into normal blood potassium group and low blood potassium group, analysed the relationship of blood potassium with serum aldosterone, plasma renin activity, angiotensin II and aldosterone/plasma renin activity ratio (ARR). Results Blood potassium of patients with primary aldosteronism was significantly correlated with aldosterone/plasma renin activity ratio. There was statistical difference in ARR value between normal blood potassium group and low blood potassium group. Conclusion Aldosterone/plasma renin ac-tivity ratio reflects its potassium level in patients with primary aldosteronism.
出处 《中国现代医药杂志》 2015年第9期23-25,共3页 Modern Medicine Journal of China
关键词 血钾 原发性醛固酮增多症 醛固酮肾素活性比值 Blood potassium Primary aldosteronism Aldosterone/plasma renin activity ratio(ARR)
  • 相关文献

参考文献10

  • 1Mulatero P,Stowasser M,Loh KC,et al. Increased diagnosis of primary aldosteronism,including surgically correctabe forms,in- centers from five continents[J]. J Clin Endocrinol Metab,2004,89(3) : 1045-1050.
  • 2White PC.Mechanism of disease :Disorders of aldosterone biosyn- thesis and action[J].N Engl J Med, 1994,331:250-258.
  • 3I-Iollenberg N,Williams G,Burger B,et al. Potassiums influence on the renal vasculature,the adrenal and their responsiveness to angiotensin 2 in normal man[J]. Clin Sci Mol Med, 1975,49:527- 534.
  • 4朱理敏,龚艳春,陈绍行,唐晓峰,陶波,陆晓虹,林伯贤,牛文全,初少莉,高平进,朱鼎良.低血钾与正常血钾原发性醛固酮增多症患者的临床特征[J].中华高血压杂志,2011,19(1):43-46. 被引量:11
  • 5Kaplan NM. Primary aldosteronism [M]//Kaplan NM. Kaplan's clini- cal hypertension. Philadelphia,PA 19106 USA:Lip pincott Willams & Wilkins,2006:410-433.
  • 6李闻鹏,张哲,郑娟兰.低血钾对原发性醛固酮增多症诊断的影响[J].上海生物医学工程,2005,26(3):173-175. 被引量:3
  • 7Rossi GP,Bernini G,Caliumi C,et al. A prospective study of the prevalence of primary aldosteronism in 1125 hypertensive patients [J]. J Am Coll Cardiol, 2006,48 ( 11 ) : 2293-2300.
  • 8邓西元,宋晓东,朱旭慧.原发醛固酮增多症亚型实验室检验结果分析[J].中华实用诊断与治疗杂志,2014,28(10):1026-1027. 被引量:6
  • 9Neville AM, Mackay MA. The structure of the adrenal cortex in health and disease[J]. Clin Endocrinol Metab, 1972,1:361-395.
  • 10Hamb Ling C,Jung RC,Browning MCK,et al. Primary hyperal- dosteronism evaluation of procedures for diagnosis and localiza- tion[J]. Q J Med, 1993,86(6) :383-392.

二级参考文献24

  • 1陈绍行,杜月凌,张瑾,龚艳春,胡亚蓉,初少莉,何清波,宋艳艳,朱鼎良.在高血压患者中筛选原发性醛固酮增多症国人血浆醛固酮/肾素活性比值标准的探讨[J].中华心血管病杂志,2006,34(10):868-872. 被引量:48
  • 2吴景程,汤正义,张炜,凌丹芸,侯瑞芳,王卫庆,李小英,宁光.单侧肾上腺结节增生性原发性醛固酮增多症的临床特点和随访结果分析[J].中华医学杂志,2006,86(46):3302-3305. 被引量:9
  • 3中国成人血脂异常防治指南[J].中华心血管病杂志,2007,35(5):390-419. 被引量:5221
  • 4Sinclair AM, Isles CG, Brown I, etal. Secondary hypertension in a blood pressure clinic[J]. Arch Intern Med, 1987,147(7) : 1289- 1293.
  • 5Mulatero P, Stowasser M, Loh KC, et al. Increased diagnosis of primary aldosteronism, including surgically eorreetable forms, in eenters from five continents[J]. J Clin Endoerinol Metab,2004,89 (3) : 1045-1050.
  • 6Hiramatsu K, Yamada T, Yukimura Y, etal. A screening test to identify aldosterone-producing adenoma by measuring plasma renin activity. Results in hypertensive patients [J]. Arch Intern Med,1981,141(12) :1589-1593.
  • 7Funder JW, Carey RM, Fardella C, et al. Case detection, diag- nosis, and treatment of patients with primary aldosteronism: an endocrine society clinical practice guideline[J]. J Clin Endocrinol Metab,2008,93(9) :3266-3281.
  • 8Stowasser M, Gordon RD, Rutherford JC, et al. Diagnosis and management of primary aldosteronism[J]. J Renin Angiotensin Aldosterone Syst,2001,2(3) : 156-169.
  • 9Devereux RB, Alonso DR, Lutas EM; et al. Echocardiographic assessment of left ventricular hypertrophy: comparison to necropsy findings[J]. Am J Cardiol, 1986,57(6) :450-458.
  • 10Graham I, Atar D, Borch-Johnsen K, et al. European guidelines on cardiovascular disease prevention in clinical practice: full text. Fourth Joint Task Force of the European Society of Cardiology and other societies on cardiovascular disease prevention in clinical practice (constituted by representatives of nine societies and by invited experts) [J]. Eur J Cardiovase Prey Rehabil, 2007,14 (Sup- pl 2):1-113.

共引文献16

同被引文献45

引证文献7

二级引证文献7

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部